Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -19.19%69.1K | -15.16%107.41K | -34.00%107.48K | -18.11%521.45K | -55.92%146.47K | 49.69%85.52K | 13.83%126.61K | 19.61%162.86K | 34.76%636.75K | 169.56%332.24K |
| Selling and administrative expenses | -21.09%54.94K | -23.09%66.89K | -40.39%87.78K | -22.02%424.45K | -60.85%120.6K | 57.44%69.63K | 25.27%86.97K | 20.11%147.26K | 603.66%544.33K | 249.65%308.08K |
| -Selling and marketing expense | ---- | ---- | ---- | 5.52%7.3K | 108.87%7.3K | --0 | --0 | ---- | -14.41%6.92K | 215.72%3.5K |
| -General and administrative expense | -21.09%54.94K | -23.09%66.89K | -40.39%87.78K | -22.38%417.15K | -62.80%113.3K | 66.87%69.63K | 26.96%86.97K | 20.11%147.26K | 675.78%537.42K | 247.17%304.58K |
| Other operating expenses | -10.87%14.16K | 2.22%40.52K | 26.29%19.7K | 4.95%96.99K | 7.04%25.87K | 23.12%15.89K | -5.16%39.64K | 15.09%15.6K | -76.61%92.42K | -92.66%24.16K |
| Operating profit | 19.19%-69.1K | 15.16%-107.41K | 34.00%-107.48K | 18.11%-521.45K | 55.92%-146.47K | -49.69%-85.52K | -13.83%-126.61K | -19.61%-162.86K | -34.76%-636.75K | -169.56%-332.24K |
| Net non-operating interest income (expenses) | 0 | 0 | 0 | -79.23%805 | 0 | 82 | -79.05%419 | -83.79%304 | 3.88K | 0 |
| Non-operating interest income | --0 | --0 | --0 | -79.23%805 | --0 | --82 | -79.05%419 | -83.79%304 | --3.88K | --0 |
| Other net income (expenses) | -12,898.63%-1.61M | -99.46%552 | -100.01%-48 | 221.85%829.8K | 82.56%376.44K | 1,808.83%12.54K | 14,054.40%103.12K | 553.22%337.69K | 290.92%257.82K | 5,103.83%206.21K |
| Gain on sale of security | -99.88%15 | 105.78%552 | -84.62%-48 | 785.76%44.02K | 743.11%41.05K | 1,808.83%12.54K | -1,191.75%-9.55K | -156.52%-26 | -109.73%-6.42K | -54.89%-6.38K |
| Special income (charges) | ---1.61M | ---- | ---- | --0 | --0 | --0 | --0 | --0 | ---1.22K | --0 |
| -Less:Impairment of capital assets | --1.61M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.22K | --0 |
| Other non-operating income (expenses) | ---- | ---- | ---- | 196.00%785.78K | 57.76%335.39K | ---- | --112.67K | 538.73%337.72K | --265.46K | --212.59K |
| Income before tax | -2,196.70%-1.67M | -363.31%-106.86K | -161.39%-107.53K | 182.43%309.16K | 282.47%229.98K | -29.08%-72.9K | 79.02%-23.06K | 312.06%175.14K | 7.75%-375.06K | 1.05%-126.03K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -2,196.70%-1.67M | -363.31%-106.86K | -161.39%-107.53K | 182.43%309.16K | 282.47%229.98K | -29.08%-72.9K | 79.02%-23.06K | 312.06%175.14K | 7.75%-375.06K | 1.05%-126.03K |
| Net income continuous operations | -2,196.70%-1.67M | -363.31%-106.86K | -161.39%-107.53K | 182.43%309.16K | 282.47%229.98K | -29.08%-72.9K | 79.02%-23.06K | 312.06%175.14K | 7.75%-375.06K | 1.05%-126.03K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -2,196.70%-1.67M | -363.31%-106.86K | -161.39%-107.53K | 182.43%309.16K | 282.47%229.98K | -29.08%-72.9K | 79.02%-23.06K | 312.06%175.14K | 7.75%-375.06K | 1.05%-126.03K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -2,196.70%-1.67M | -363.31%-106.86K | -161.39%-107.53K | 182.43%309.16K | 282.47%229.98K | -29.08%-72.9K | 79.02%-23.06K | 312.06%175.14K | 7.75%-375.06K | 1.05%-126.03K |
| Diluted earnings per share | -0.06 | -0.01 | 0 | 200.00%0.01 | 0.01 | 0 | 0 | 415.46%0.01 | 50.00%-0.01 | 0 |
| Basic earnings per share | -0.06 | -0.01 | 0 | 200.00%0.01 | 0.01 | 0 | 0 | 415.46%0.01 | 50.00%-0.01 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.